<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0007">
 <label>[7]</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Maezawa</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nguyen</surname>
    <given-names>HM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Di Lucente</surname>
    <given-names>J</given-names>
   </name>, et al
  </person-group>
  <article-title>Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept</article-title>. 
  <source>Brain</source>. 
  <year>2018</year>;
  <volume>141</volume>(
  <issue>2</issue>):
  <fpage>596</fpage>–
  <lpage>612</lpage>.
  <pub-id pub-id-type="pmid">29272333</pub-id>
 </mixed-citation>
</ref>
